| Title |
Quality of life of patients with lung cancer
|
|---|---|
| Published in |
OncoTargets and therapy, February 2016
|
| DOI | 10.2147/ott.s100685 |
| Pubmed ID | |
| Authors |
Jacek Polanski, Beata Jankowska-Polanska, Joanna Rosinczuk, Mariusz Chabowski, Anna Szymanska-Chabowska |
| Abstract |
Lung cancer is the major cause of oncologic-related death worldwide. Due to delayed diagnosis, 5-year survival rate accounts for only 15%. Treatment includes surgery, adjuvant chemotherapy, and radiation therapy; however, it is burdened by many side effects. Progress of the disease, severity of its symptoms, and side effects decrease significantly the quality of life (QoL) in those patients. The level of self-assessed QoL helps in predicting survival, which is especially important among patients receiving palliative care. Patients assess their functioning in five dimensions (physical, psychological, cognitive, social, and life roles), severity of symptoms, financial problems, and overall QoL. The QoL in lung cancer patients is lower than in healthy population and patients suffering from other malignancies. It is affected by the severity and the number of symptoms such as fatigue, loss of appetite, dyspnea, cough, pain, and blood in sputum, which are specific for lung tumors. Fatigue and respiratory problems reduce psychological dimension of QoL, while sleep problems reduce cognitive functioning. Physical dimension (related to growing disability) decreases in most of the patients. Also, most of them are unable to play their family and social roles. The disease is a frequent reason of irritation, distress, and depression. Management of the disease symptoms may improve QoL. Controlling the level of fatigue, pulmonary rehabilitation, and social and spiritual support are recommended. Early introduction of tailored palliative treatment is a strategy of choice for improvement of QoL in lung cancer patients. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Italy | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 422 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 1 | <1% |
| Germany | 1 | <1% |
| Turkey | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 417 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 57 | 14% |
| Student > Bachelor | 55 | 13% |
| Student > Ph. D. Student | 31 | 7% |
| Researcher | 25 | 6% |
| Student > Doctoral Student | 21 | 5% |
| Other | 75 | 18% |
| Unknown | 158 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 21% |
| Nursing and Health Professions | 64 | 15% |
| Psychology | 17 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Biochemistry, Genetics and Molecular Biology | 14 | 3% |
| Other | 53 | 13% |
| Unknown | 172 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 175. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 December 2022.
All research outputs
#231,225
of 25,461,852 outputs
Outputs from OncoTargets and therapy
#5
of 3,021 outputs
Outputs of similar age
#4,139
of 406,974 outputs
Outputs of similar age from OncoTargets and therapy
#1
of 95 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 406,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 95 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.